Healthy adult vaccination: An urgent need to prevent hepatitis B in China. Issue 3 (3rd March 2016)

• Record Type: Journal Article
• Authors: Qiu, Yan; Ren, Jingjing; Yao, Jun
• Is Part Of: Human vaccines & immunotherapeutics. Volume 12:Issue 3(2016)
• Page Start: 773
• Page End: 778
• Publication Date: 2016-03-03
• Subjects: China -- hepatitis B -- healthy adults -- immunization -- prevalence; Vaccines -- Periodicals; 615.372
• DOI: 10.1080/21645515.2015.1086519
• Languages: English
• ISSNs: 2164-5515

Abstract

Abstract: Prevalence of hepatitis B is still high among adults in China, athough the prevalence in children has decreased dramatically. Immunization against hepatitis B among adults is urgently required. Through analyzing the immunogenicity of different doses, schedules and booster immunization among adults, we recommend 10 or 20 μg with a 0-1-6-month schedule or a 0-1-12-month schedule for migrant adults. For immunity failure, increasing the dose or covalent vaccine is suggested to provide protective antibodies. To enhance immunity among adults, hepatitis B vaccine should be included in health insurance.